Effective Therapy for MDS is Vastly Underused, Especially in Female and Non-White Patients
August 07, 2025
August 07, 2025
WASHINGTON, Aug. 7 -- The American Society of Hematology issued the following news release on Aug. 6, 2025:
* * *
Effective Therapy for MDS is Vastly Underused, Especially in Female and Non-White Patients
Over half of eligible patients do not receive recommended therapies or complete the full course of treatment; white males are most likely to get the right treatment at the right dose
*
Most patients with high-risk myelodysplastic . . .
* * *
Effective Therapy for MDS is Vastly Underused, Especially in Female and Non-White Patients
Over half of eligible patients do not receive recommended therapies or complete the full course of treatment; white males are most likely to get the right treatment at the right dose
*
Most patients with high-risk myelodysplastic . . .